Jordy Cohen, MD, MSCE

@jordy_bc

Nephrologist, epidemiologist, physician scientist/ESI, 4-season hiker/mountaineer, , , , ,

cceb.med.upenn.edu/bio/jordana-co…
Vrijeme pridruživanja: travanj 2015.
131 fotografija ili videozapis Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @jordy_bc

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @jordy_bc

  1. Prikvačeni tweet
    10. lip 2019.

    Due to mixed results across the existing literature, we asked: Does white coat really matter? 1/4

    6 replies 36 proslijeđenih tweetova 78 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    4. velj

    I have always questioned whether morning surge is predictive for CVD among those who have a high prevalence of hypertension during sleep. The higher the asleep BP the less the morning surge. We examined this question in the Jackson Heart Study.

    10 proslijeđenih tweetova 22 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  3. proslijedio/la je Tweet
    4. velj

    Curious if and how folks are incorporating home BP measurements into HEDIS quality reporting. Seems these need to be automatically transmitted to providers but can’t be manually reported by patients.

    3 proslijeđena tweeta 7 korisnika označava da im se sviđa
    Poništi
  4. proslijedio/la je Tweet
    3. velj

    The CRIC Study is accepting applications to fund innovative studies using CRIC participant data through its Opportunity Pool. Letters of intent due 2/7/20.

    9 proslijeđenih tweetova 10 korisnika označava da im se sviđa
    Poništi
  5. proslijedio/la je Tweet
    31. sij
    Odgovor korisnicima i sljedećem broju korisnika:

    here i was, innocently checking on twitter before going home.... this is going to take a while to sift through. There science to be pursued from their findings, but it put masked hypertension on the CMMS radar and led to a proposed change in ABPM reimbursement. what is next?

    1 reply 2 proslijeđena tweeta 6 korisnika označava da im se sviđa
    Poništi
  6. 30. sij

    Apparently there will be an update/correction soon. No word on the impact on the results

    1 reply 1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  7. proslijedio/la je Tweet
    30. sij

    Would we be better off having people recheck all analyses that get published?

    This is quite shocking: Banegas et al. Spanish ABPM Registry Study retracted from NEJM. Curious to learn more FYI
    Prikaži ovu nit
    1 proslijeđeni tweet 5 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  8. 30. sij

    This is quite shocking: Banegas et al. Spanish ABPM Registry Study retracted from NEJM. Curious to learn more FYI

    9 replies 24 proslijeđena tweeta 47 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  9. proslijedio/la je Tweet
    29. sij

    14 fellowship alumni in the past 10 years are now faculty!

    1 proslijeđeni tweet 18 korisnika označava da im se sviđa
    Poništi
  10. proslijedio/la je Tweet
    27. sij

    Hypertension is either an outpatient problem or an ICU problem.

    27 replies 75 proslijeđenih tweetova 722 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  11. proslijedio/la je Tweet
    27. sij

    Our paper on orthostatic hypotension in is out! Big thanks to all the co-authors who made this possible. Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events | Hypertension

    11 proslijeđenih tweetova 20 korisnika označava da im se sviđa
    Poništi
  12. proslijedio/la je Tweet
    25. sij

    The viral thread quoted below is missing essential context and contains numerous errors. It does not reflect the latest evidence. Here is a new thread with the facts:

    Tweet je nedostupan.
    4.501 proslijeđeni tweet 7.325 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  13. proslijedio/la je Tweet
    24. sij
    Odgovor korisnicima i sljedećem broju korisnika:

    The point I'm trying to raise is lots of results of 'wearables' will come out now and always the focus is on the mean...what about the SDD - and is 17 ok? 8 has been chosen at the AAMI level, but if many clinicians saw the rationale for 8, they would say it's too lax! 2/2

    1 reply 2 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi
  14. proslijedio/la je Tweet
    23. sij

    Interesting paper from and others. First study comparing a wearable watch-type monitor with a conventional ambulatory monitor.

    11 proslijeđenih tweetova 21 korisnik označava da mu se sviđa
    Poništi
  15. 17. sij

    Thanks for having me at !! Had a wonderful time — extremely interesting discussions w

    . from giving on BP measurement in CKD
    Prikaži ovu nit
    1 proslijeđeni tweet 17 korisnika označava da im se sviđa
    Poništi
  16. proslijedio/la je Tweet
    16. sij

    Very elegant analysis of HFpEF patients that sheds light on the different patterns of HFpEF that ring true with what we see in our HF clinic. Hopefully the PARAGON-HF investigators are paying attention & can add analyses to this discussion

    Excited to see our paper posted online ! We asked: were there differences in mechanistic biomarkers, cardiac/arterial function, and response to spironolactone among clinical phenogroups of HFpEF in TOPCAT
    Prikaži ovu nit
    1 reply 3 proslijeđena tweeta 7 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  17. 15. sij

    Congrats to Laura! She is an amazing nephrologist and research scientist that we have the pleasure to learn from everyday

    Annually we award the prestigious J. Michael Lazarus Award to a specialist in the field of who exemplifies our relentless efforts to enhance the lives of patients.
    7 korisnika označava da im se sviđa
    Poništi
  18. proslijedio/la je Tweet
    10. sij

    Can anyone explain why JAK2 mutations and P. vera might cause renal artery lesions? or is this just a chance occurence, and not really causative.

    6 proslijeđenih tweetova 15 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  19. 9. sij

    We concluded that separation of individuals into clinically identifiable subgroups can help to identify patients who have the potential to benefit most from targeted interventions in future trials of HFpEF patients

    2 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  20. 9. sij

    Grp 1 was younger w/normal LV structure & ⬇️events Grp 2 was older w/stiff vessels, ⬆️BNP, innate immune activation, & ⬆️mortality Grp 3 had obesity/diabetes, TNF-a-inflammation, liver/kidney injury, ⬆️HF 🏥, and ⬇️adverse outcomes among those randomized to spironolactone

    1 reply 1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  21. 9. sij

    We found evidence of 3 phenogroups based on commonly assessed clinical characteristics, each with different underlying biomarker profiles, LV structures/function, and outcomes.

    1 reply 2 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi

@jordy_bc još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·